Sally Walsh
Papers
1
Total Citations
47
H-Index
1
About
Dr. Sally Walsh has made transformative contributions to clinical cytogenetics, particularly through the validation and implementation of array comparative genomic hybridisation (CGH) as a first-line diagnostic test for genomic imbalance. Her landmark 2010 study, cited 47 times, demonstrated that array CGH could reliably replace traditional postnatal karyotyping, offering a substantial increase in diagnostic yield for patients with suspected chromosomal abnormalities. This work helped shift clinical practice toward higher-resolution genome-wide analysis, improving detection of submicroscopic imbalances that conventional G-banding would miss. Beyond this pivotal study, Dr. Walsh has been instrumental in establishing robust protocols for array-based testing in routine diagnostics, ensuring accuracy and reproducibility in clinical settings. Her research has directly impacted how genetic laboratories approach postnatal testing, reducing reliance on lower-resolution methods and enabling earlier, more precise diagnoses for individuals with developmental disorders and congenital anomalies. By bridging the gap between research innovation and clinical implementation, Dr. Walsh has advanced the standard of care in medical genetics, with her work serving as a foundational reference for laboratories worldwide transitioning to array-based genomic analysis.
Research Focus
Key Achievements
Top Papers
- 1